Novo Nordisk
NVO
#15
Rank
HK$4.660 T
Marketcap
HK$1,051
Share price
2.14%
Change (1 day)
44.09%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): HK$131.79 B

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are HK$131.37 B. In 2023 the company made an earning of HK$120.27 B an increase over its 2022 earnings that were of HK$76.29 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$131.79 B9.58%
2023 HK$120.27 B57.64%
2022 HK$76.29 B5.35%
2021 HK$72.42 B12.47%
2020 HK$64.39 B13.07%
2019 HK$56.95 B-3.35%
2018 HK$58.92 B1.79%
2017 HK$57.88 B4.52%
2016 HK$55.38 B9.42%
2015 HK$50.61 B8.24%
2014 HK$46.76 B3.45%
2013 HK$45.20 B19.02%
2012 HK$37.98 B15.21%
2011 HK$32.96 B17.71%
2010 HK$28.00 B24.78%
2009 HK$22.44 B10.62%
2008 HK$20.28 B55.97%
2007 HK$13.00 B7.07%
2006 HK$12.14 B18.18%
2005 HK$10.28 B11.33%
2004 HK$9.23 B
2002 HK$6.07 B-14.39%
2001 HK$7.09 B-52.82%
2000 HK$15.03 B250%
1999 HK$4.29 B31.21%
1998 HK$3.27 B34.31%
1997 HK$2.43 B11.46%
1996 HK$2.18 B9.03%
1995 HK$2.00 B-3.15%
1994 HK$2.07 B-0.67%
1993 HK$2.08 B45.38%
1992 HK$1.43 B-13.81%
1991 HK$1.66 B37.12%
1990 HK$1.21 B-0.79%
1989 HK$1.22 B26.2%
1988 HK$0.96 B24.97%
1987 HK$0.77 B-0.9%
1986 HK$0.78 B-7.78%
1985 HK$0.84 B24.87%
1984 HK$0.67 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$9.45 B-107.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$70.07 B-46.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$50.04 B-138.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$52.61 B-59.95%๐Ÿ‡ซ๐Ÿ‡ท France